Pasithea Therapeutics (KTTA) Accumulated Depreciation & Amortization (2022 - 2024)
Pasithea Therapeutics (KTTA) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $5000.0 as the latest value for Q3 2024.
- Quarterly Accumulated Depreciation & Amortization fell 73.36% to $5000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Sep 2024, down 73.36% year-over-year, with the annual reading at $23488.0 for FY2023, 559.96% up from the prior year.
- Accumulated Depreciation & Amortization hit $5000.0 in Q3 2024 for Pasithea Therapeutics, down from $32920.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $32920.0 in Q2 2024 to a low of $3559.0 in Q4 2022.
- Historically, Accumulated Depreciation & Amortization has averaged $18657.3 across 3 years, with a median of $21130.0 in 2023.
- Biggest five-year swings in Accumulated Depreciation & Amortization: surged 559.96% in 2023 and later crashed 73.36% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $3559.0 in 2022, then soared by 559.96% to $23488.0 in 2023, then plummeted by 78.71% to $5000.0 in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for KTTA at $5000.0 in Q3 2024, $32920.0 in Q2 2024, and $28205.0 in Q1 2024.